University of AmsterdamUniversity of AmsterdamUvA

  • Terms of use
  • Contact

UvA-DARE (Digital Academic Repository)

  • Home
  • Advanced Search
  • Browse
  • My selection

Search UvA-DARE

Author
P.W. Friederich
Title
Novel anticoagulant and prohemostatic strategies
Supervisors
M.M. Levi
H.R. Büller
Co-supervisors
B.J. Biemond
Award date
12 September 2000
Number of pages
225
ISBN
9090139788
9789090139784
Document type
PhD thesis
Faculty
Faculty of Medicine (AMC-UvA)
Note
Research conducted at: CRIA
Permalink
http://hdl.handle.net/11245/1.172908
Downloads
  • Thesis

  • Cover

  • Titlepage

  • Contents

  • CHAPTER 1 GENERAL INTRODUCTION

  • CHAPTER 2 COMPARISON OF SUSTAINED ANTITHROMBOTIC EFFECTS OF INHIBITORS OF THROMBIN AND FACTOR Xa IN EXPERIMENTAL THROMBOSIS

  • CHAPTER 3 SUCCESSFUL ATTENUATION OF VENOUS THROMBUS GROWTH IN RABBITS AFTER THE ADMINISTRATION OF A NOVEL ORAL THROMBIN INHIBITOR

  • CHAPTER 4 A NOVEL DIRECT SPECIFIC THROMBIN INHIBITOR (S 18326) ATTENUATES THROMBUS GROWTH AND ENHANCES THROMBOLYSIS IN A RABBIT VENOUS THROMBOSIS MODEL

  • CHAPTER 5 A NOVEL LOW MOLECULAR WEIGHT INHIBITOR OF PAI-1 (XR5118) REDUCES POST-THROMBOLYSIS THROMBUS GROWTH AND PROMOTES ENDOGENOUS FIBRINOLYSIS IN RABBITS

  • CHAPTER 6 APOLIPOPROTEIN(A) ATTENUATES ENDOGENOUS FIBRINOLYSIS IN THE RABBIT JUGULAR VEIN THROMBOSIS MODEL IN VIVO

  • CHAPTER 7 ENHANCEMENT OF RABBIT JUGULAR VEIN THROMBOLYSIS BY NEUTRALIZATION OF FACTOR XI: IN VIVO EVIDENCE FOR A ROLE OF FACTOR XI AS AN ANTI-FIBRINOLYTIC FACTOR

  • CHAPTER 8 FIBRINOGEN-COATED ALBUMIN MICROCAPSULES REDUCE BLEEDING IN SEVERELY THROMBOCYTOPENIC RABBITS.

  • CHAPTER 9 THE ABILITY OF RECOMBINANT FACTOR VIIa TO GENERATE THROMBIN DURING INHIBITION OF THE TISSUE FACTOR/FACTOR VIIa COMPLEX IN HUMAN SUBJECTS

  • CHAPTER 10 ACTIVATION OF COAGULATION BY ADMINISTRATION OF RECOMBINANT FACTOR VIIA ELICITS INTERLEUKIN (IL)-6 AND IL-8 RELEASE IN HEALTHY HUMAN SUBJECTS

  • CHAPTER 11 RECOMBINANT ACTIVATED FACTOR VII: A UNIVERSAL HEMOSTATIC AGENT?

  • CHAPTER 12 REDUCTION OF PERIOPERATIVE BLOOD LOSS AND TRANSFUSION REQUIREMENT IN PATIENTS UNDERGOING TRANSABDOMINAL RETROPUBIC PROSTATECTOMY BY ADMINISTRATION OF RECOMBINANT ACTIVATED FACTOR VII

  • CHAPTER 13 SUCCESSFUL TREATMENT WITH RECOMBINANT FACTOR VIIA OF THERAPY-RESISTANT SEVERE BLEEDING IN A PATIENT WITH ACQUIRED VON WILLEBRAND DISEASE

  • Co-authors

  • Samenvatting

  • Dankwoord

  • Curriculum Vitae

  • Publications

  • Cover

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

PrintPrint this pageShareShare via emailShare on facebookShare on linkedinShare on twitter
  • University library
  • About UvA-DARE
  • Disclaimer
Copyright UvA 2014